Nicolas Venisse

9PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsEnvironmental biogeochemistryGroundwater quality processes and contaminated land assessmentBioavailability and ecotoxicologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Dec 09, 2025
Detection of Endocrine Disruptors in Human Placenta: A Pilot Study on Exposure and Histopathological Findings.

Mickael Robalo, Sarah Ayraud-Thévenot, Virginie Migeot

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|May 25, 2024
N-Ethylhexedrone: A very long and bad trip! A case series.

Sandrine Lefeuvre, Camille Richeval, Jeremy Lelong

|Aug 16, 2023
Exposure to endocrine disruptors promotes biofilm formation and contributes to increased virulence of Pseudomonas aeruginosa.

Audrey Thiroux, Jérôme Labanowski, Nicolas Venisse

|Jan 23, 2023
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.

Sihem Benaboud, Caroline Solas, Stephane Bouchet

Pageof 2

Frequent Collaborators

3 joint publications

Florian Lemaitre

3 joint publications

Minh Patrick Lê

3 joint publications

Gilles Peytavin

2 joint publications

Antoine Dupuis